Literature DB >> 6834592

Possible association of Guillain-Barré syndrome with thrombolytic therapy.

K V Eden.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6834592     DOI: 10.1001/jama.1983.03330390028021

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Guillain-Barré syndrome after treatment with streptokinase.

Authors:  D Barnes; R A Hughes
Journal:  BMJ       Date:  1992-05-09

Review 2.  Intravenous streptokinase. A reappraisal of its therapeutic use in acute myocardial infarction.

Authors:  K L Goa; J M Henwood; J F Stolz; M S Langley; S P Clissold
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

3.  Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction.

Authors:  H D White; D B Cross; B F Williams; R M Norris
Journal:  Br Heart J       Date:  1990-09

4.  Guillain-Barré syndrome following streptokinase therapy.

Authors:  R Kaiser; R Kaufmann; M Czygan; H Lang; C H Lücking
Journal:  Clin Investig       Date:  1993-10

5.  Occurrence of Guillain-Barré syndrome as an immune mediated complication after thrombolysis with streptokinase for acute anterior wall myocardial infarction: a caution to be vigilant.

Authors:  Basant Kumar; Navin Agrawal; Soumya Patra; C N Manjunath
Journal:  BMJ Case Rep       Date:  2013-10-07

Review 6.  Adverse reactions to thrombolytic agents. Implications for coronary reperfusion following myocardial infarction.

Authors:  J Nazari; R Davison; K Kaplan; D Fintel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

Review 7.  Streptokinase. A review of its pharmacology and therapeutic efficacy in acute myocardial infarction in older patients.

Authors:  P E Battershill; P Benfield; K L Goa
Journal:  Drugs Aging       Date:  1994-01       Impact factor: 3.923

8.  Guillain-barré syndrome after thrombolysis with streptokinase.

Authors:  Ertugrul Okuyan; Mehmet Akif Cakar; Mustafa H Dinckal
Journal:  Cardiol Res Pract       Date:  2010-12-26       Impact factor: 1.866

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.